Mesenchymal stem cells‐derived IL‐6 promotes invasion and metastasis of oral squamous cell carcinoma via JAK‐STAT3 signalling - Liu, Chuanxia; Zhou, Jinhan; Zhang, Shanshan; Fu, Ji; Li, Yining; Hao, Yilong; Yuan, Jian; Tang, Fan; Ge, Weili; He, Hong; Chen, Qianming (Oral diseases, 2024)
Keywords: Animals; Antibodies, Monoclonal, Humanized - pharmacology; Antibodies, Monoclonal, Humanized - therapeutic use; cancer progression; Carcinoma, Squamous Cell - metabolism; Carcinoma, Squamous Cell - pathology; Carcinoma, Squamous Cell - secondary; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytokines; Epithelial-Mesenchymal Transition; Female; Humans; Interleukin 6; Interleukin-6 - metabolism; Janus Kinases - metabolism; Lymph nodes; Male; Malignancy; Medical diagnosis; Medical prognosis; mesenchymal stem cell; Mesenchymal stem cells; Mesenchymal Stem Cells - metabolism; Metastases; Metastasis; Mice; Mice, Nude; Molecular modelling; Monoclonal antibodies; Mouth Neoplasms - metabolism; Mouth Neoplasms - pathology; Neoplasm Invasiveness; Neoplasm Metastasis; Oral cancer; Oral carcinoma; Oral squamous cell carcinoma; Signal Transduction; Squamous cell carcinoma; Stat3 protein; STAT3 Transcription Factor - metabolism; Stem cells; Survival analysis; Tumors; Xenografts; interleukin 6; mesenchymal stem cell; oral squamous cell carcinoma; cancer progression; metastasis